Combined Synopsis/Solicitation · 75R60226R00026
HRSA/MCHB Newborn Screening Systematic Evidence Review IDIQ and Task Order 1
The Health Resources and Services Administration, Maternal and Child Health Bureau (HRSA/MCHB) is releasing this full and open competitive solicitation to establish a Multiple-Award pool of approximately three (3) to five (5) Indefinite-Delivery, Indefinite-Quantity (IDIQ) contracts. The primary objective is to secure highly specialized scientific methodologies, systematic clinical evidence reviews, and core programmatic support for the Newborn Screening Recommended Uniform Screening Panel (RUSP). The master IDIQ ordering period is five (5) years (a 12-month Base Period plus four sequential 12-month Option Periods) with an aggregate collective ceiling value of $15,111,361.00. 2. Acquisition Framework & RFO Protocols This commercial services procurement is being conducted under the dual frameworks of FAR Part 12 (Commercial Products and Services) and the streamlined negotiated procedures of FAR Part 15 under the Revolutionary FAR Overhaul (RFO) framework. 3. Concurrent Track 1 Award St…
Excerpt as published. The complete description, attachments, and any amendments are on the official notice.
GrantSet indexes public records and is not the official application channel. Responses and applications go through SAM.gov only — the official notice there controls if anything shown here differs.